Hot Warren Buffett Companies To Watch In Right Now

New Jersey Gov. Chris Christie's secret gastric band surgery in�February�has stolen front-page headlines today. His weight is often the target of comedic fodder, but it was a legitimate concern surrounding his overall health.

This news has gotten the political media stirring that the governor is planning a White House run in 2016, but here at the Fool we're more concerned with investing than with politics. With more than 200,000 stomach-shrinking procedures performed per year, is there money to be made for investors?

In this video, Motley Fool health-care analyst David Williamson takes a closer look at the companies and highlights why this may be no slam-dunk for investors.

What could be a slam-dunk for investors is a stock working to eradicate the macro trend Warren Buffett called "the tapeworm that's eating at American competitiveness." Find out what Buffett was referring to in our free report: "What's Really Eating at America's Competitiveness." Just click here for free, immediate access.

Hot Trucking Stocks To Watch Right Now: Qualys Inc (QLYS)

Qualys, Inc. (Qualys), incorporated on December 30, 1999, is a provider of clouds security and compliance solutions that enable organizations to identify security risks to their information technology (IT) infrastructures, help protect their IT systems and applications from cyber attacks and achieve compliance with internal policies and external regulations. The Company designed its QualysGuard Cloud Platform to transform the way organizations secure and protect their IT infrastructures and applications. The Company's cloud platform offers an integrated suite of solutions that automates the lifecycle of asset discovery, security assessments, and compliance management for an organization's IT infrastructure and assets, whether they reside inside the organization, on their network perimeter or in the cloud.

The Company provides its solutions through a software-as-a-service model, primarily with renewable annual subscriptions. These subscriptions require customers to pay a fee in order to access the Company's cloud solutions. The Company's QualysGuard Cloud Platform consists of a suite of IT security and compliance solutions that leverage the Company's shared and extensible core services and its scalable multi-tenant cloud infrastructure. The Company's suite of solutions provides security intelligence by automating the life cycle of IT asset discovery, security assessment and compliance management. The Company's cloud platform's infrastructure includes integrated services that deliver a automated and scalable scanning infrastructure capable of scanning IT systems and Web applications, inside and outside corporate firewalls. The Company also provides open application program interfaces (APIs), and other developer tools that allow third parties to embed its technology into their solutions and build applications on its cloud platform.

The Company's suite of solutions, which the Company refers to as the QualysGuard Cloud Suite, includes Vulnerability Management, Web Application Sca! nning, Malware Detection Service, Policy Compliance, PCI Compliance and Qualys SECURE Seal. The Company's customers can subscribe to one or more of the Company's security and compliance solutions based on their initial needs and expand their subscriptions over time to new areas within their organization or to additional QualysGuard solutions. The Company offers two editions of its QualysGuard Cloud Suite, the Enterprise edition for large and medium-sized enterprises and the Express edition for small and medium-sized businesses.

QualysGuard Vulnerability Management (QualysGuard VM), is a solution that automates network auditing and vulnerability management across an organization, including network discovery and mapping, asset management, vulnerability reporting, and remediation tracking. QualysGuard Policy Compliance (QualysGuard PC) allows customers to analyze and collect configuration and access control information from their networked devices and Web applications and automatically maps this information to internal policies and external regulations in order to document compliance.

QualysGuard PCI Compliance (QualysGuard PCI) provides organizations that store cardholder data a automated solution to verify and document compliance with PCI DSS. QualysGuard Web Application Scanning (QualysGuard WAS) uses the scalability of its cloud platform to allow customers to discover, catalog and scan a large number of Web applications. QualysGuard Malware Detection Service (QualysGuard MDS) provides organizations with the ability to scan identify and remove malware infections from their Websites. QualysGuard Web Application Firewall (QualysGuard WAF) delivers enterprise-grade Web application security without associated with appliance-based Web application firewall solutions. QualysGuard SECURE Seal helps organizations demonstrate to their online customers that they maintain a proactive security program.

Core Services include asset tagging and management, reporting and dashboards! , questio! nnaires and collaboration, remediation and workflow, big data correlation and analytics engine, and alerts and notifications. The Company�� infrastructure layer, which it refer to as its Infrastructure, includes the data, data processing capabilities, software and hardware infrastructure and infrastructure management capabilities that provide the foundation for its cloud platform and allow the Company to automatically scale its Infrastructure and Core Services to scan millions of Internet protocols (IPs).

The Company competes with Hewlett-Packard Company, Imperva, Inc., International Business Machines Corporation, McAfee, Inc., Symantec Corporation, Barracuda Networks, Inc., BeyondTrust Software, Inc., Lumension Security, Inc., nCircle Network Security, Inc., NetIQ Corporation, Rapid7 LLC, Tenable Network Security, Inc. and Trustwave Holdings, Inc.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading UP
  Qualys (NASDAQ: QLYS) shares shot up 8.24 percent to $20.68 after the company reported upbeat quarterly results.

  Shares of Office Depot (NYSE: ODP) got a boost, shooting up 15.95 percent to $4.84 after the company reported upbeat quarterly earnings and announced its plans to close at least 400 stores in the US.

Hot Warren Buffett Companies To Watch In Right Now: DexCom Inc.(DXCM)

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. The company also provides the SEVEN PLUS, which incorporates additional user interface and algorithm enhancements that are intended to make its glucose monitoring function customizable. Its SEVEN PLUS has FDA and CE Mark approvals. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for conti nuously monitoring blood glucose levels in patients hospitalized for various conditions. It also has development agreement with Insulet Corporation to integrate its continuous glucose monitoring technology into Insulet?s wireless, handheld OmniPod System Personal Diabetes Manager; and a joint development agreement with Animas Corporation to integrate its continuous glucose monitoring technology into Animas insulin pumps. The company was founded in 1999 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Sean Williams]

  Where's the beef, DexCom?
  Sometimes a company's products make a lot of sense on paper, but the practical application doesn't go nearly as smoothly. This is how I'd describe medical monitoring device maker DexCom (NASDAQ: DXCM  ) , which has an array of glucose monitoring devices to help diabetes patients better manage their disease. Make no mistake about it; the number of diabetes diagnoses in this country is rising in accord with our obesity rate. Therefore, a company like DexCom, which makes the DexCom G4 System monitor, could be a big hit, and certainly has a wide enough audience to cater to.

Hot Warren Buffett Companies To Watch In Right Now: Rigel Pharmaceuticals Inc.(RIGL)

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.

Advisors' Opinion:

• [By Sean Williams]

  It wasn't nearly as exciting a week for Rigel Pharmaceuticals (NASDAQ: RIGL  ) , which regained full rights to rheumatoid arthritis pill Fostamatinib from AstraZeneca�on Tuesday. The pair actually reported a statistically significant ACR20 response rate at 24 weeks in two trials, but the data isn't expected to be conclusive enough to gain FDA approval. AstraZeneca, not wanting to spend any more on the program, took a $140 million charge and returned all licensing back to Rigel. With the prospect of high trial costs and a drug which did well, but perhaps not well enough to compete with competition already on the market, Rigel is now in a tough position and is worth avoiding at all costs.

• [By Sean Williams]

  What: Shares of Rigel Pharmaceuticals (NASDAQ: RIGL  ) , a clinical-stage small molecule drug company focused on inflammatory and autoimmune disorders, dropped as much as 21% after the company resumed full responsibility for its rheumatoid arthritis pill, Fostamatinib, and reported topline data from two late-stage studies involving the drug.

• [By Maxx Chatsko]

  Rigel Pharmaceuticals (NASDAQ: RIGL  ) was kicked in the stomach earlier this month, when AstraZeneca (NYSE: AZN  ) returned full rights for fostamatinib. The Big Pharma member decided to write off $140 million of assets attributed to the partnership rather than take the next steps in commercializing the drug for rheumatoid arthritis. Ouch. While it's a smart idea for AstraZeneca to walk away now, Rigel is in a tough spot with its top drug candidate receiving a vote of no confidence. There is a handful of companies that stand to benefit from fostamatinib's failure. In the following video, Fool contributor Maxx Chatsko explains what it means for investors and what the future could hold for the development-stage company. �

Hot Warren Buffett Companies To Watch In Right Now: Bravo Enterprises Ltd (OGNG)

Bravo Enterprises Ltd., formerly Organa Gardens International Inc., incorporated on November 29, 1983, is a development-stage company. The Company holds an undivided 85% working interest and an undivided 68% net revenue interest in 13,189 acres located in Wasatch County, Utah, known as the Uinta Basin and a 0.7% gross overriding royalty interest on 6,360 acres of oil and natural gas rights located in the Powder River Basin of eastern Wyoming. The Company has a vertical hydroponics farming system. The Company owns a 2% royalty interest in the Harvester Property. The LAK Ranch field covers approximately 7,500 acres in the Powder River basin. In September 2011, the Company completed its merger agreement with Integrated Green Technologies LLC.

The Organa Garden Systems (OGS) provide a means for food production and consumption change to global and ecological through vertical hydroponics rotary farming. There are two OGS models; the Discovery (OGS-D) and the Enterprise (OGS-E). Its specially designed waterwheel technology allows the fully automated system to recycle and reuse 95% of the water used while requiring a negligible amount of energy to run.

Advisors' Opinion:

• [By Peter Graham]

  Small cap green stocks Vision Industries Corp (OTCMKTS: VIIC), Bravo Enterprises Ltd (OTCMKTS: OGNG) and Kleangas Energy Technologies Inc (OTCMKTS: KGET) have reported recent news and/or they are being promoted. Of course, it goes without saying that small cap green stocks tend to be more volatile that other types of investments. So will investors and traders alike see some greenbacks from these green stocks? Here is a quick reality check:

Hot Warren Buffett Companies To Watch In Right Now: Transdigm Group Incorporated(TDG)

TransDigm Group Incorporated designs, produces, and supplies engineered aircraft components for use on commercial and military aircraft principally in the United States. The company?s products include mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, pumps and valves, power conditioning devices, AC/DC electric motors and generators, NiCad batteries and chargers, engineered latching and locking devices, rods and locking devices, engineered connectors and elastomers, cockpit security components and systems, cockpit displays, aircraft audio systems, lavatory components, engineered interior surfaces, and lighting and control technology. Its customers comprise distributors of aerospace components; commercial airlines, including national and regional airlines; commercial transport and regional and business aircraft original equipment manufacturers (OEMs); various armed forces of the United States and foreign governments; defense OEMs; system suppliers; and various other industrial customers. TransDigm Group Incorporated was founded in 1993 and is based in Cleveland, Ohio.

Advisors' Opinion:

• [By Brendan Mathews]

  We asked which current CEOs fit the�Outsiders�mold. Thorndike reeled off a short list of names, but he started with Michael Pearson of�Valeant Pharmaceuticals� (NYSE: VRX  ) . He went on to mention Nicholas Howley of�TransDigm Group� (NYSE: TDG  ) , and Rich Kinder of�Kinder Morgan� (NYSE: KMI  ) .�

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on TransDigm Group (NYSE: TDG  ) , whose recent revenue and earnings are plotted below.

• [By Eric Volkman]

  TransDigm (NYSE: TDG  ) is rewarding its shareholders mightily with an extraordinary payout. The company has declared a special dividend of $22.00 per share, which will be paid on July 25 to shareholders of record as of July 15.

Hot Warren Buffett Companies To Watch In Right Now: World Wrestling Entertainment Inc.(WWE)

World Wrestling Entertainment, Inc., an integrated media and entertainment company, engages in the sports entertainment business. The company develops content centered around its talent, and presents at its live and televised events featuring World Wrestling Entertainment. It operates through four segments: Live and Televised Entertainment, Consumer Products, Digital Media, and WWE Studios. The Live and Televised Entertainment segment conducts live events; produces television shows; sells merchandise at its live events; provides sponsorships, such as various promotional vehicles, including Internet and print advertising, arena signage, on-air announcements, and pay-per-view sponsorships for advertisers; offers television rights; and markets and promotes the storylines associated with pay-per-view events. It also provides WWE Classics On Demand, a subscription video on demand service that offers classic television shows, pay-per-view events, specials, and original programmi ng. This segment distributes its programming in approximately 30 languages and in approximately 145 countries. Its merchandise consists of various WWE-branded products, such as T-shirts, caps, and other novelty items. The Consumer Products segment licenses and sells retail products, including toys, video games, home videos, apparel, and books; and publishes magazines comprising lifestyle publications with native language editions in the UK, Mexico, Greece, and Turkey. The Digital Media segment operates Web sites; provides advertising services; sells merchandise on its Web site at WWEShop Internet storefront; and offers broadband and mobile content. The WWE Studios segment is involved in the distribution of entertainment films. This segment focuses on creating a mix of filmed entertainment. The company was founded in 1980 and is based in Stamford, Connecticut.

Advisors' Opinion:

• [By Matt Egan]

  WWE (WWE) revealed plans on Thursday to slash 7% of its workforce in an effort to save cash.

  A WWE spokesman said the job cuts will impact all business units and locations. He said the pink slips will begin flying on Thursday.

• [By Lisa Levin]

  World Wrestling Entertainment (NYSE: WWE) shares gained 1.21% to create a new 52-week high of $13.36. World Wrestling Entertainment has a dividend yield of 3.70%.

• [By Monica Gerson]

  World Wrestling Entertainment (NYSE: WWE) shares dropped 44.81% to $11.00 in pre-market trading following announcement of NBCUniveral deal on Thursday.

• [By Luke Jacobi]

  Shares of World Wrestling Entertainment (NYSE: WWE) were down 43.28 percent into the close to $11.31 following announcement of NBCUniversal deal on Thursday. Benchmark downgraded WWE from Buy to Hold.